Scott Tuten - Danimer Scientific Chief Marketing and Sustainability Officer

DNMRDelisted Stock  USD 1.79  0.41  18.64%   

Insider

Scott Tuten is Chief Marketing and Sustainability Officer of Danimer Scientific since 2020.
Age 49
Tenure 5 years
Phone229 243 7075
Webhttps://www.danimerscientific.com

Scott Tuten Latest Insider Activity

Tracking and analyzing the buying and selling activities of Scott Tuten against Danimer Scientific otc stock is an integral part of due diligence when investing in Danimer Scientific. Scott Tuten insider activity provides valuable insight into whether Danimer Scientific is net buyers or sellers over its current business cycle. Note, Danimer Scientific insiders must abide by specific rules, including filing SEC forms every time they buy or sell Danimer Scientific'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Danimer Scientific Management Efficiency

The company has return on total asset (ROA) of (0.088) % which means that it has lost $0.088 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.459) %, meaning that it created substantial loss on money invested by shareholders. Danimer Scientific's management efficiency ratios could be used to measure how well Danimer Scientific manages its routine affairs as well as how well it operates its assets and liabilities.
Danimer Scientific currently holds 408.07 M in liabilities with Debt to Equity (D/E) ratio of 0.61, which is about average as compared to similar companies. Danimer Scientific has a current ratio of 6.47, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Danimer Scientific until it has trouble settling it off, either with new capital or with free cash flow. So, Danimer Scientific's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Danimer Scientific sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Danimer to invest in growth at high rates of return. When we think about Danimer Scientific's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Valerie PetersOlin Corporation
61
Jeffrey KutzAir Products and
64
Gregory BrennemanEcovyst
58
Susan WardEcovyst
59
Robert CPAOrion Engineered Carbons
65
J KuijpersEastman Chemical
N/A
Felipe SmithSociedad Quimica y
N/A
Susan SuarezGonzalezInternational Flavors Fragrance
49
Thomas SchnebergerEcovyst
51
Raymond KolbergEcovyst
58
Ana MunozSociedad Quimica y
N/A
Martin CraigheadEcovyst
60
Matthias HeinzelDupont De Nemours
54
Sandra NiewiemOrion Engineered Carbons
48
Timothy WalshEcovyst
56
Kathy VanLandinghamLyondellBasell Industries NV
N/A
William KarlsonAir Products and
N/A
Rose LeeDupont De Nemours
54
Deanna MulliganDupont De Nemours
56
Kimberly LubelWestlake Chemical
56
Mary LindseyOrion Engineered Carbons
65
Danimer Scientific, Inc., a performance polymer company, develops, produces, and provides bioplastic replacements for traditional petroleum-based plastics. Danimer Scientific, Inc. was founded in 2004 and is headquartered in Bainbridge, Georgia. Danimer Scientific operates under Specialty Chemicals classification in the United States and is traded on New York Stock Exchange. It employs 282 people. Danimer Scientific [DNMR] is traded as part of a regulated electronic over-the-counter service offered by the NASD. Danimer Scientific is listed under Chemicals category by Fama And French industry classification.

Management Performance

Danimer Scientific Leadership Team

Elected by the shareholders, the Danimer Scientific's board of directors comprises two types of representatives: Danimer Scientific inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Danimer. The board's role is to monitor Danimer Scientific's management team and ensure that shareholders' interests are well served. Danimer Scientific's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Danimer Scientific's outside directors are responsible for providing unbiased perspectives on the board's policies.
James Palczynski, Investor Officer
Stuart Pratt, Director
Stephen Esq, Corporate Officer
Russ Zukowski, Vice Finance
Anthony Austin, Chief Officer
Richard Altice, Interim Director
Christy Basco, Independent Director
Gregory Hunt, Independent Director
Richard Hendrix, Independent Director
John Dowdy, Chief Financial Officer
Philip Calhoun, Independent Director
John III, Senior Analysis
Michael Hajost, Chief Financial Officer
Michael Smith, Chief Operating Officer
Phillip Trump, Chief Science and Technology Officer
Stephen Croskrey, Chairman of the Board, Chief Executive Officer
John Amboian, Independent Director
Deborah McRonald, Chief Officer
Scott Tuten, Chief Marketing and Sustainability Officer
Isao Noda, Independent Director

Danimer Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Danimer Scientific a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Danimer Scientific

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Danimer Scientific position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Danimer Scientific will appreciate offsetting losses from the drop in the long position's value.

Moving together with Danimer OTC Stock

  0.76DD Dupont De Nemours Fiscal Year End 4th of February 2025 PairCorr
  0.85FF FutureFuel CorpPairCorr

Moving against Danimer OTC Stock

  0.77WTTR Select Energy ServicesPairCorr
  0.71ECVT EcovystPairCorr
The ability to find closely correlated positions to Danimer Scientific could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Danimer Scientific when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Danimer Scientific - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Danimer Scientific to buy it.
The correlation of Danimer Scientific is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Danimer Scientific moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Danimer Scientific moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Danimer Scientific can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Danimer Scientific. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Consideration for investing in Danimer OTC Stock

If you are still planning to invest in Danimer Scientific check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Danimer Scientific's history and understand the potential risks before investing.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals